Table 2.
Association of TyG index with baPWV at baseline and baPWV progression in linear models
TyG index | Model 1 | Model 2 | ||
---|---|---|---|---|
β(95% CI) | P value | β(95% CI) | P value | |
baPWV at baseline | ||||
Per 1 unit increase | 75 (66–85) | < 0.001 | 39 (29–48) | < 0.001 |
Q1 (6.81–8.10) | Reference | Reference | ||
Q2 (8.10–8.52) | 36 (18–55) | < 0.001 | 19 (2–36) | 0.032 |
Q3 (8.52–9.02) | 88 (69–110) | < 0.001 | 50 (32–67) | < 0.001 |
Q4 (9.02–13.17) | 140 (120–160) | < 0.001 | 71 (52–90) | < 0.001 |
baPWV progression | ||||
Per 1 unit increase | 0.42 (0.31–0.54) | < 0.001 | 0.29 (0.17–0.42) | < 0.001 |
Q1 (6.81–8.10) | Reference | Reference | ||
Q2 (8.10–8.52) | 0.41 (0.19–0.64) | < 0.001 | 0.34 (0.11–0.57) | 0.003 |
Q3 (8.52–9.02) | 0.67 (0.44–0.91) | < 0.001 | 0.52 (0.29–0.76) | < 0.001 |
Q4 (9.02–13.17) | 0.72 (0.48–0.96) | < 0.001 | 0.45 (0.20–0.71) | < 0.001 |
N = 6028; TyG index, triglyceride–glucose index; baPWV, brachial-ankle pulse wave velocity; CI, confidence interval; Q, quartiles
Model 1, adjusted for age and sex at baseline
Model 2, adjusted for variables in model 1 plus smoking, alcohol drinking, physical activity, MAP, diabetes, hs-CRP, and BMI at baseline